相关实验视频

Updated: Feb 27, 2026

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

在非典型帕金森综合征中对多神经病的纵向评估

Eun Hae Kwon¹, Julia Steininger¹, Antonia Bieber¹

¹Department of Neurology, St. Josef-Hospital, Ruhr-University, D-44791 Bochum, Germany.

Neurology international

|February 26, 2026

概括

多神经病变 (PNP) 在非典型帕金森综合征 (APS) 中很常见,影响了超过一半的多系统缩 (MSA) 和渐进性上核 (PSP) 患者. 在MSA中PNP进展可能表明疾病进展.

科学领域:

神经科学是一个神经科学.
神经学神经学
临床电生理学临床电生理学

背景情况:

在帕金森病 (PD) 中,多神经病 (PNP) 的患病率很高,但其在非典型的帕金森综合征 (APS) 中的作用,如多系统缩 (MSA) 和渐进性超核性 (PSP) 是不充分研究的.
初步数据表明,在APS中PNP的患病率较高,需要进一步调查.

研究的目的:

纵向评估MSA和PSP患者PNP的临床和电生理进展.
探索PNP与疾病严重程度,认知功能和MSA和PSP进展之间的关联.

主要方法:

神经传导研究在基线和两年随访期间在13名MSA和9名PSP患者中进行.
在排除二次原因后,PNP诊断遵循标准的电生理学标准.
临床评估包括运动和非运动评估.

主要成果:

在基线时,53.8%的MSA患者和66.7%的PSP患者有PNP.
患有PNP的MSA患者表现出更严重的运动症状和更差的认知表现.
仅在MSA患者中,在两年内观察到神经幅度的显著下降,与疾病进展相关.

结论:

这项研究提供了关于MSA和PSP中PNP进展的第一个纵向数据,揭示了APS的高并发症.
PNP可能会导致APS患者的运动和感觉缺陷,其进展可能作为MSA进展的标志物.
需要进行更大规模的研究来证实PNP是APS的生物标志物,并区分外围神经参与的同核蛋白病变与型神经病变.

关键词:

非典型的帕金森综合征.在纵向的长度上.多个系统缩.神经传导研究神经传导研究多性神经病症多性神经病症.渐进性的超核性麻.

更多相关视频

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Assessment of Sensorimotor Function in Mouse Models of Parkinson's Disease

Published on: June 17, 2013

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...